Beleaguered Battery Maker Soon to Get a Jolt
NEW YORK (TheStreet) -- Investors and fishermen have three favorite stories: the trophy they landed, the beauty that got away and the monster they've been watching in a favorite fishing spot.
For my inaugural article on TheStreet, I'm going to share my perspective on Axion Power International (AXPW), a micro-cap battery-technology developer with an ugly price history that obscures a brilliant future.
I'm not a disinterested observer when it comes to Axion. I was the company's board chairman from 2004 to 2007, and I own a substantial block of stock that I bought at four times the current price in the fall of 2006. I'm down 75% on paper, but I've never felt better about my risk-reward profile.
First, some history. Axion was formed in late 2003 to conduct R&D on a hybrid battery that pairs a lead-based positive electrode with a carbon negative electrode assembly. Like most developments in the battery industry, Axion's PbC battery involves trade-offs. Replacing the lead-based negative electrode with a carbon electrode assembly reduces the specific energy of the battery, which makes it a poor choice for storing large amounts of electricity for applications that need long periods of sustained discharge.
On the other hand, the electrode substitution results in a battery that charges as much as 20 times faster than a normal lead-acid battery and doesn't suffer from a phenomenon known as sulfation, the primary cause of lead-acid battery failure. That means Axion's PbC battery can offer up to 10 times the useful service life in applications that cycle frequently. It's not a silver bullet for all the world's energy-storage needs, but it's well-suited for emerging applications in alternative energy, automotive and railroads. For its first five years, Axion was a low-profile R&D stock with a very illiquid market that traded about 15,000 shares a day. At March 24, 2009, the 38.9 million equivalent common shares outstanding gave Axion a market cap of $35 million, which was about right for a late-stage R&D outfit with no product, no revenue and no visible industry relationships. Things started to get interesting in April 2009 when Axion announced a worldwide supply agreement with Exide Technologies (XIDE), which promised to take the PbC from the laboratory bench to the factory floor. The company got downright fascinating in August 2009 when the Department of Energy awarded a $34 million ARRA Battery Manufacturing Grant to "Exide Technologies with Axion Power International." The grant was originally seen as wonderful news, but it also created some tension between the companies because Exide had control over the money and Axion believed it deserved a share of the grant because the PbC technology was a core element of the application. When Axion went looking for additional financing in December 2009, unresolved questions about whether it would share the grant made price negotiations tough, and Axion was forced to accept a deep discount for a $26 million private placement that went off at $0.57 and more than doubled the share count from 38.9 million to 84.6 million. That offering created a huge supply-and-demand imbalance that's distorted trading for the past 2 1/2 years. The following graph tracks two key statistics since January 2009. The daily closing price is in blue and the 60-day average trading volume is in red. If you spend some time studying the chart, a classic lesson in stock market supply-and-demand dynamics begins to emerge.Select the service that is right for you!
COMPARE ALL SERVICESAction Alerts PLUS
TRY IT FREEJim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.
Product Features:
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
TheStreet Quant Ratings
TRY IT FREENew! $49.95/yr
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
Product Features:
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
Stocks Under $10
TRY IT FREEDavid Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.
Product Features:
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts
- Weekly roundups
Dividend Stock Advisor
TRY IT FREEJim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
Product Features:
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
TRY IT FREEAll of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.
Product Features:
- Real Money + Doug Kass + 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
Options Profits
TRY IT FREEOur options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.
Product Features:
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV